サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768552

ハイブリッドイメージングの世界市場

Hybrid Imaging

出版日
ページ情報
英文 231 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
ハイブリッドイメージングの世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 231 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ハイブリッドイメージングの世界市場は2030年までに米国で134億米ドルに到達

2024年に101億米ドルと推定されるハイブリッドイメージングの世界市場は、2024年から2030年にかけてCAGR 4.9%で成長し、2030年には134億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるPET/CTシステムは、CAGR 4.9%を記録し、分析期間終了時には47億米ドルに達すると予測されます。SPET/CTシステム分野の成長率は、分析期間でCAGR 5.5%と推定されます。

米国市場は28億米ドル、中国はCAGR4.7%で成長予測

米国のハイブリッドイメージング市場は2024年に28億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに21億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.5％と4.1％と予測されています。欧州では、ドイツがCAGR 4.8%で成長すると予測されています。

世界のハイブリッドイメージング市場- 主要動向と促進要因のまとめ

ハイブリッドイメージングが医療診断に革命をもたらす理由とは？

ハイブリッドイメージングは、陽電子放射断層撮影法（PET）や磁気共鳴画像法（MRI）など、2つ以上の画像モダリティを組み合わせて、より包括的な診断情報を提供することで、医療診断における大きな進歩を象徴しています。これらのハイブリッド・システムは、1回のスキャンで機能的データと解剖学的データの両方を提供することにより、疾患の検出、診断、モニタリング能力を向上させる。例えば、PET-MRIは優れた軟部組織コントラストと機能的イメージングを提供し、これはがん、神経疾患、心血管疾患の発見に不可欠です。さまざまな画像技術を統合することで、より正確な診断、治療計画の改善、患者の予後の改善が可能になり、ハイブリッドイメージングは現代のヘルスケアに欠かせないツールとなっています。

技術の進歩はハイブリッドイメージング市場をどのように形成していますか？

技術革新は、ハイブリッドイメージングシステムの進化において極めて重要な役割を果たしています。検出器技術、画像再構成アルゴリズム、データ処理の進歩により、ハイブリッドイメージング装置の精度とスピードが向上しています。例えば、デジタル検出器の開発により、PET-CTやSPECT-CTシステムの感度と解像度が向上し、より鮮明な画像と疾患の早期発見につながりました。さらに、AIを活用した画像解析ツールがハイブリッドイメージングのワークフローに統合されつつあり、より迅速な解釈と診断精度の向上を可能にしています。また、ハイブリッドイメージングシステムはよりコンパクトでアクセスしやすくなっているため、外来診療所や小規模なヘルスケア施設での利用が拡大し、市場の裾野が広がっています。

市場セグメンテーションはハイブリッドイメージング市場の成長にどう影響するか？

モダリティには、PET-CT、PET-MRI、SPECT-CTがあり、PET-CTは腫瘍検出と治療モニタリングのために腫瘍学で広く使用されているため、最大の市場シェアを占めています。ハイブリッドイメージングのアプリケーションは、腫瘍学、神経学、心臓病学、整形外科学など多岐にわたるが、世界のがん罹患率の増加により、腫瘍学が主要なアプリケーション分野となっています。エンドユーザーには、病院、画像診断センター、研究機関が含まれ、病院は高度な画像診断インフラを備えているため、最大の市場シェアを占めています。また、ハイブリッドイメージングが治療効果の評価や治療アプローチのカスタマイズに使用される個別化医療アプリケーションも成長しています。

ハイブリッドイメージング市場の成長を促進する要因は？

ハイブリッドイメージング市場の成長は、慢性疾患の有病率の上昇、画像診断モダリティの技術的進歩、早期かつ正確な診断に対する需要の増加など、いくつかの要因によって牽引されています。がん、心血管疾患、神経疾患の世界の負担が増加の一途をたどるなか、ヘルスケアプロバイダーは診断精度の向上と治療方針の決定にハイブリッドイメージングを活用するようになっています。画像処理におけるAIと機械学習の統合は、ハイブリッドイメージングシステムの精度と効率を高め、臨床現場での価値を高めています。また、個別化医療の普及と発展途上地域におけるヘルスケアインフラの拡大が、ハイブリッドイメージング技術の需要を促進しています。

セグメント

タイプ（PET/CTシステム、SPET/CTシステム、PET/MRシステム、OCT/眼底イメージングシステム、その他のタイプ）、用途（腫瘍学、眼科、循環器学、脳・神経学、その他の用途）、最終用途（病院、画像診断センター、その他の最終用途）

調査対象企業の例

  • Bruker
  • Canon Medical Systems Corp.
  • Cubresa, Inc.
  • Fujifilm VisualSonics, Inc.
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Mediso Ltd.
  • MILabs B.V.
  • MR Solutions
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • TriFoil Imaging

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP21999

Global Hybrid Imaging Market to Reach US$13.4 Billion by 2030

The global market for Hybrid Imaging estimated at US$10.1 Billion in the year 2024, is expected to reach US$13.4 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. PET / CT Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the SPET / CT Systems segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 4.7% CAGR

The Hybrid Imaging market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Hybrid Imaging Market - Key Trends and Drivers Summarized

Why Is Hybrid Imaging Revolutionizing Medical Diagnostics?

Hybrid imaging represents a significant advancement in medical diagnostics by combining two or more imaging modalities, such as Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI), to provide more comprehensive diagnostic information. These hybrid systems enhance the ability to detect, diagnose, and monitor diseases by offering both functional and anatomical data in a single scan. For instance, PET-MRI provides superior soft-tissue contrast and functional imaging, which is critical for detecting cancer, neurological disorders, and cardiovascular diseases. The integration of different imaging technologies allows for more accurate diagnoses, improved treatment planning, and better patient outcomes, making hybrid imaging an indispensable tool in modern healthcare.

How Are Technological Advancements Shaping the Hybrid Imaging Market?

Technological innovations are playing a pivotal role in the evolution of hybrid imaging systems. Advances in detector technologies, image reconstruction algorithms, and data processing have improved the precision and speed of hybrid imaging devices. For example, the development of digital detectors has enhanced the sensitivity and resolution of PET-CT and SPECT-CT systems, leading to sharper images and earlier disease detection. Moreover, AI-driven image analysis tools are increasingly being integrated into hybrid imaging workflows, allowing for faster interpretation and improved diagnostic accuracy. Hybrid imaging systems are also becoming more compact and accessible, which is expanding their use in outpatient clinics and smaller healthcare facilities, broadening the market's reach.

How Do Market Segments Influence the Growth of the Hybrid Imaging Market?

Modalities include PET-CT, PET-MRI, and SPECT-CT, with PET-CT holding the largest market share due to its widespread use in oncology for tumor detection and treatment monitoring. Applications of hybrid imaging span across oncology, neurology, cardiology, and orthopedics, with oncology being the dominant application area due to the increasing global burden of cancer. End-users include hospitals, diagnostic imaging centers, and research institutions, with hospitals accounting for the largest market share because of their advanced imaging infrastructure. The market is also witnessing growth in personalized medicine applications, where hybrid imaging is used to assess treatment efficacy and tailor therapeutic approaches.

What Factors Are Driving the Growth in the Hybrid Imaging Market?

The growth in the hybrid imaging market is driven by several factors, including the rising prevalence of chronic diseases, technological advancements in imaging modalities, and increasing demand for early and accurate diagnosis. As the global burden of cancer, cardiovascular diseases, and neurological disorders continues to rise, healthcare providers are increasingly relying on hybrid imaging to improve diagnostic precision and guide treatment decisions. The integration of AI and machine learning in image processing is enhancing the accuracy and efficiency of hybrid imaging systems, making them more valuable in clinical settings. Additionally, the growing adoption of personalized medicine and the expansion of healthcare infrastructure in developing regions are fueling the demand for hybrid imaging technologies.

SCOPE OF STUDY:

The report analyzes the Hybrid Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System, Other Types); Application (Oncology, Ophthalmology, Cardiology, Brain & Neurology, Other Applications); End-Use (Hospitals, Diagnostic Imaging Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Bruker
  • Canon Medical Systems Corp.
  • Cubresa, Inc.
  • Fujifilm VisualSonics, Inc.
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Mediso Ltd.
  • MILabs B.V.
  • MR Solutions
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • TriFoil Imaging

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Hybrid Imaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Multi-Modal Imaging in Diagnostics Propels Growth in Hybrid Imaging
    • Technological Advancements in PET-CT and SPECT-CT Strengthen the Business Case for Hybrid Imaging
    • Increasing Adoption of Hybrid Imaging in Oncology and Cardiology Expands Addressable Market
    • Growing Focus on Early Disease Detection and Precision Medicine Drives Demand for Hybrid Imaging Systems
    • Government Initiatives to Improve Healthcare Infrastructure Spur Market Adoption of Hybrid Imaging
    • Rising Interest in Personalized and Non-Invasive Diagnostic Solutions Fuels Hybrid Imaging Demand
    • Expansion of Hybrid Imaging Applications in Neurology and Orthopedics Creates New Market Opportunities
    • Integration of AI and Machine Learning in Hybrid Imaging Accelerates Market Innovation
    • Growing Focus on Reducing Diagnostic Errors Strengthens the Case for Hybrid Imaging
    • Rising Prevalence of Chronic Diseases and Aging Population Drives Demand for Hybrid Imaging Solutions
    • Increasing Adoption of Mobile and Portable Hybrid Imaging Devices Creates New Opportunities
    • Technological Innovations in Image Fusion and Resolution Enhance the Efficiency of Hybrid Imaging Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Hybrid Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Hybrid Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Hybrid Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Brain & Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Hybrid Imaging Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for PET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for PET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for PET / CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for SPET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for SPET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for SPET / CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for PET / MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for PET / MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for PET / MR Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for OCT / Fundus Imaging System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for OCT / Fundus Imaging System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for OCT / Fundus Imaging System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Hybrid Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Hybrid Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of World 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of World 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION